Insider · CIK 0001724489
Vida Ventures, LLC
Files at KYTX (Kyverna Therapeutics, Inc.). First filing Feb 14, 2024, latest Feb 14, 2024.
In brief
Vida Ventures, LLC files SEC Form 4 as 10% owner at KYTX (Kyverna Therapeutics, Inc.). Since Feb 14, 2024, Vida Ventures, LLC has reported 1 open-market buy worth $5.6M and 0 open-market sells worth $0, the latest filed on Feb 14, 2024.
A track record needs three past buys with six months of prices behind them; Vida Ventures, LLC has 0, so none is measured yet.
The newest scored trade: bought $5.6M of KYTX on Feb 12, 2024, filed Feb 14, 2024, scored 65 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KYTX: Kyverna Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | Kyverna Therapeutics, Inc. | $5.6M 253,136 shares | - | 0% from low-1% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | KYTX Kyverna Therapeutics, Inc. | CConversion Common Stockindirect: By Vida Ventures, LLC | +4,523,924 | - | - | 4,523,924 | Feb 14, 2024 |
| Feb 12, 2024 | KYTX Kyverna Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Vida Ventures III, L.P. | +252,553 | $22.00 | $5.6M | 252,553 | Feb 14, 2024 |
| Feb 12, 2024 | KYTX Kyverna Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Vida Ventures III-A, L.P. | +583 | $22.00 | $13k | 583 | Feb 14, 2024 |
| Feb 12, 2024 | KYTX Kyverna Therapeutics, Inc. | CConversion Series A-1 Redeemable Convertible Preferred Stockderivativeindirect: By Vida Ventures, LLC | -4,401,771 | $0.00 | $0 | 0 | Feb 14, 2024 |
| Feb 12, 2024 | KYTX Kyverna Therapeutics, Inc. | CConversion Series A-2 Redeemable Convertible Preferred Stockderivativeindirect: By Vida Ventures, LLC | -8,830,901 | $0.00 | $0 | 0 | Feb 14, 2024 |
| Feb 12, 2024 | KYTX Kyverna Therapeutics, Inc. | CConversion Series B Redeemable Convertible Preferred Stockderivativeindirect: By Vida Ventures, LLC | -7,356,162 | $0.00 | $0 | 0 | Feb 14, 2024 |
Questions about Vida Ventures, LLC
Answered from the filings on this page, as of the latest one.
Is Vida Ventures, LLC buying or selling?
Not in the last 12 months. Vida Ventures, LLC's latest open-market trade on SEC Form 4 was bought $5.6M of KYTX on Feb 12, 2024.
How did Vida Ventures, LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vida Ventures, LLC has 0.
Where does Vida Ventures, LLC file Form 4?
Vida Ventures, LLC has filed Form 4 at KYTX (Kyverna Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.